A Study of Evaluating the Safety and Efficacy of ATG-008 for Advanced Solid Tumors (BUNCH)
Clinical trial NCT04518137 · TERMINATED
Trial details
- NCT number
- NCT04518137
- Sponsor
- Shanghai Antengene Corporation Limited
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-09
- Primary completion
- 2022-05-30
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.